Retatrutide 32 mg supplied as a pre-filled multi-dose research pen. Retatrutide is a synthetic GIP, GLP-1 and glucagon receptor tri-agonist peptide studied in preclinical receptor-pharmacology and metabolic models. Supplied strictly for laboratory research. Not for human or veterinary use.
Retatrutide 64 mg supplied as a pre-filled multi-dose research pen. Retatrutide is a synthetic GIP, GLP-1 and glucagon receptor tri-agonist peptide studied in preclinical receptor-pharmacology and metabolic models. Supplied strictly for laboratory research. Not for human or veterinary use.
Tirzepatide 60 mg supplied as a pre-filled multi-dose research pen. Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied in preclinical receptor-pharmacology and metabolic models. Supplied strictly for laboratory research. Not for human or veterinary use.
Tirzepatide 30 mg supplied as a pre-filled multi-dose research pen. Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied in preclinical receptor-pharmacology and metabolic models. Supplied strictly for laboratory research. Not for human or veterinary use.
Tesamorelin 32 mg supplied as a pre-filled multi-dose research pen. Tesamorelin is a synthetic growth-hormone-releasing hormone (GHRH) analogue used in laboratory studies of the somatotropic axis. Supplied strictly for laboratory research. Not for human or veterinary use.
MOTS-c 32 mg supplied as a pre-filled multi-dose research pen. MOTS-c is a 16-amino-acid mitochondrial-derived peptide used in laboratory studies of mitochondrial signalling and metabolic homeostasis. Supplied strictly for laboratory research. Not for human or veterinary use.
Metabolic research peptides are synthetic ligands for the GLP-1, GIP and glucagon receptor family, together with mitochondrial-derived peptides such as MOTS-c. In laboratory settings they are used to characterise receptor binding, downstream cAMP signalling, gene expression and energy-metabolism pathways in cell culture and preclinical models.
Receptor coverage
Retatrutide is a tri-agonist at GIP, GLP-1 and glucagon receptors; Tirzepatide is a dual GIP/GLP-1 agonist. Receptor selectivity and potency, not the milligram quantity on the label, define how each compound behaves in a comparative assay.
How are they supplied?
Each compound is supplied as a sealed, pre-filled multi-dose research pen with a batch-specific Certificate of Analysis (HPLC purity and identity), dispatched from the UK in plain outer packaging. Supplied strictly for laboratory research. Not for human or veterinary use.
Research use only. For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application. This product is not a medicine, food, dietary supplement or cosmetic, and no medical, therapeutic or performance claims are made or implied. Read our research-use policy.